Gastrointestinal malignant non Hodgkin's B cell lymphomas in the immunocompetent patient (Review)

  • Authors:
    • Nada Alsaigh
    • Franz Fogt
  • View Affiliations

  • Published online on: January 1, 2003     https://doi.org/10.3892/or.10.1.3
  • Pages: 3-8
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The gastrointestinal tract is the most common site for extranodal non Hodgkin's lymphomas with B cell lymphomas being the most commonly encountered. The clinical symptoms and endoscopic findings are non-specific, however, the first obtained biopsy establishes the diagnosis in more than three quarters of the patients. Recognizing early lesions and differentiating lymphomas from hyperplastic reactive lesions may be difficult, but essential. As the classification of these lesions has been the subject of much controversy in the past, we reviewed the literature and summarized the distinct recognizable entities. We high-lighted recent advances in understanding clinical and histological findings in these lesions with adjunct immunohistochemistry and cytogenetics.

Related Articles

Journal Cover

January-February 2003
Volume 10 Issue 1

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Alsaigh N and Alsaigh N: Gastrointestinal malignant non Hodgkin's B cell lymphomas in the immunocompetent patient (Review). Oncol Rep 10: 3-8, 2003
APA
Alsaigh, N., & Alsaigh, N. (2003). Gastrointestinal malignant non Hodgkin's B cell lymphomas in the immunocompetent patient (Review). Oncology Reports, 10, 3-8. https://doi.org/10.3892/or.10.1.3
MLA
Alsaigh, N., Fogt, F."Gastrointestinal malignant non Hodgkin's B cell lymphomas in the immunocompetent patient (Review)". Oncology Reports 10.1 (2003): 3-8.
Chicago
Alsaigh, N., Fogt, F."Gastrointestinal malignant non Hodgkin's B cell lymphomas in the immunocompetent patient (Review)". Oncology Reports 10, no. 1 (2003): 3-8. https://doi.org/10.3892/or.10.1.3